The Strategic Advisory Group of Experts (SAGE) on Immunization1 met on 2–4 April 2019. This report summarises their discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on Immunization met on 23–25 October 2018. This report summarises the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 17–18 April 2018. This report summarises the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 17–19 October 2017. This report summarises the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 25–27 April 2017. This report summarises the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 18–20 October 2016 in Geneva, Switzerland. This report summarizes the discussions, conclusions and recommendations.Report from the WHO Department of Immunization, Vaccines and Biologicals
The Effectiveness of Pertussis Immunisation in Children (EPIC) study data provides good evidence that the current National Immunisation Schedule protects against severe pertussis in infants and children. The pertussis vaccine provides moderate protection against severe disease after two doses and good protection after three doses. No evidence of waning immunity was shown following dose three up to age four years or following 3P+1 doses up to age seven years.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 14–16 April 2015 in Geneva, Switzerland. This report summarizes the discussions, conclusions and recommendations.
The Strategic Advisory Group of Experts (SAGE) on immunization met on 20–22 October 2015 in Geneva, Switzerland. This report summarizes the discussions, conclusions and recommendations.
Childhood immunisation is one of the priority health targets for New Zealand. Despite having made excellent progress in gaining high immunisation rates in the past ten years, we have not fully attained the stated goals of 95% fully immunised at 2 years and 8 months of age.